S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Inovio Pharmaceuticals to Independently Develop Prostate Cancer Immunotherapy; Will Maintain Collaboration and License Agreement with Roche for Inovio's Hepatitis B Immunotherapy|
|Inovio Pharmaceuticals Reports 2014 Third Quarter Financial Results|
|Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers|
|Inovio Pharmaceuticals Melanoma DNA Immunotherapy Inhibits Tumor Growth and Increases Survival in Preclinical Study|
|Inovio Pharmaceuticals HIV Immunotherapy Shows Characteristics Considered Vital to Treating HIV|
|Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology|
|Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market|
|Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index|
|Inovio Pharmaceuticals' CEO to Present at 2015 Biotech Showcase Conference|
|Inovio Pharmaceuticals to Report Third Quarter 2014 Financial Results on November 10, 2014|
Click above to view more mutual fund data and stats for ino - Inovio Pharmaceuticals Inc.